ReviewFrontiers in immunology2026
Post-translational modification networks as master regulators of influenza virus replication, host adaptation, and immune evasion.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Influenza viruses remain major global health threats due to their rapid evolution and complex interactions with host regulatory systems. While genetic variation is a key driver of viral pathogenicity and host adaptation, growing evidence indicates that post-translational modifications (PTMs) provide an additional regulatory layer that can influence viral replication, immune evasion, and metabolic remodeling. In this review, we synthesize current knowledge on how coordinated PTM networks, including phosphorylation, ubiquitination, SUMOylation, glycosylation, acetylation, lipidation, and RNA methylation, are implicated across multiple stages of the influenza virus life cycle. Accumulating studies indicate that phosphorylation and ubiquitin signaling can fine-tune polymerase activity and ribonucleoprotein trafficking, whereas SUMOylation and acetylation modulate polymerase function and host immune antagonism. Glycosylation remodeling of viral glycoproteins is closely associated with antigenic evolution and immune escape, while epitranscriptomic RNA methylation and PTM-linked metabolic pathways reshape host environments in ways that may support replication. Notably, many mechanistic insights derive from cell-based or model organism systems, and the relative contribution of specific PTM events during human infection remains incompletely defined. A systems-level view of PTM networks highlights emerging regulatory vulnerabilities at the host-virus interface and supports further evaluation of PTM-modulating enzymes as potential targets for host-directed antiviral and vaccine strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.